Home » Topics » BioWorld Science

BioWorld Science
RSS

Increased clotting contributes to cardiovascular risk in HIV-infected individuals

June 18, 2019

Luspatercept MOA: Up for grabs?

June 18, 2019

Inhibiting CCL24 with CM-101 reduces fibrosis and inflammation in systemic sclerosis

June 18, 2019

Gilead initiates phase I study of GS-1423 in advanced solid tumors

June 18, 2019

LNC helps TNBC go AWOL

June 18, 2019

Telaglenastat doubles PFS in heavily pretreated patients with advanced RCC in ENTRATA trial

June 17, 2019

Antibody-antibiotic conjugate DSTA-4637S well tolerated in phase I study

June 17, 2019

Extracellular vesicles deliver antiaging enzyme

June 17, 2019

Elthera receives funding through E.U.'s Horizon 2020 program

June 17, 2019

TLC reports data from part 1 of phase II bunionectomy trial of TLC-590

June 17, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...